Approval · Notice of Compliance 14534 · 2013
NTP-ACYCLOVIR: Notice of Compliance 14534
Issued July 5, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14534
- Date
- July 5, 2013
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative merger/buyout
- Therapeutic class
- Antiviral agent
- Canadian reference product
- ZORIVAX (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NTP-ACYCLOVIR | 02367513 | Cancelled Pre Market |
| NTP-ACYCLOVIR | 02367521 | Cancelled Pre Market |
| NTP-ACYCLOVIR | 02367548 | Cancelled Pre Market |